CRISPR
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade CRISPR 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About CRSP
CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA.
CEOSamarth Kulkarni
CEOSamarth Kulkarni
Employees393
Employees393
HeadquartersZug, Zug
HeadquartersZug, Zug
Founded2013
Founded2013
Employees393
Employees393
CRSP Key Statistics
Market cap5.50B
Market cap5.50B
Price-Earnings ratio-10.07
Price-Earnings ratio-10.07
Dividend yield—
Dividend yield—
Average volume1.79M
Average volume1.79M
High today$57.99
High today$57.99
Low today$55.30
Low today$55.30
Open price$56.18
Open price$56.18
Volume961.62K
Volume961.62K
52 Week high$78.48
52 Week high$78.48
52 Week low$30.04
52 Week low$30.04
Stock Snapshot
The current CRISPR(CRSP) stock price is $57.72, with a market capitalization of 5.5B. The stock trades at a price-to-earnings (P/E) ratio of -10.07.
On 2026-01-14, CRISPR(CRSP) stock moved within a range of $55.30 to $57.99. With shares now at $57.72, the stock is trading +4.4% above its intraday low and -0.5% below the session's peak.
Trading activity shows a volume of 961.62K, compared to an average daily volume of 1.79M.
The stock's 52-week range extends from a low of $30.04 to a high of $78.48.
The stock's 52-week range extends from a low of $30.04 to a high of $78.48.
CRSP News
TipRanks 2d
CRISPR Therapeutics Highlights Pipeline Advances in Gene-Edited TherapiesClaim 70% Off TipRanks Premium Crispr Therapeutics AG ( (CRSP) ) just unveiled an update. On January 12, 2026, CRISPR Therapeutics issued an update on its pip...
Analyst ratings
57%
of 30 ratingsBuy
56.7%
Hold
40%
Sell
3.3%
People also own
Based on the portfolios of people who own CRSP. This list is generated using Robinhood data, and it’s not a recommendation.